Stocksigma LogoStocksigma Logo

NCLT Approves Scheme Application for Vilin Bio Med and Chemgenix Merger

NCLT Hyderabad Bench-I, via order dated 10th Sep'26, allowed the first-stage joint scheme application for the merger by absorption of Chemgenix

NCLT Approves Scheme Application for Vilin Bio Med and Chemgenix Merger

Vilin Bio Med Ltd 路 Others 路 11 Sept 2026, 8:44 pm

NCLT Approves Scheme Application for Vilin Bio Med and Chemgenix Merger NCLT Hyderabad Bench-I, via order dated 10th Sep'26, allowed the first-stage joint scheme application for the merger by absorption of Chemgenix Laboratories Private Limited into Vilin Bio Med Limited. The tribunal dispensed with the meeting of Chemgenix's equity shareholders following 100% consent. It directed convening meetings of Chemgenix's creditors, alongside public shareholders and unsecured creditors of Vilin Bio Med, on 15th Oct'26. The share exchange ratio is set at 1:1, offering 1 equity share of Vilin Bio Med (Rs.10 each) for every 1 share of Chemgenix.

Original exchange filing (PDF)

More announcements from Vilin Bio Med Ltd

All Vilin Bio Med Ltd announcements